People – Page 2
-
NewsThe RESTART trial: a drug to block a toxic HIV molecule
What if the presence of a well-known but misunderstood viral protein explains why some people living with HIV (PLWH) never recover their health, even with antiretroviral treatment? Researchers will explore this in a groundbreaking clinical trial this fall.
-
NewsSummer studentship: Shen explores how a novel peptide can destabilise the outer membrane of E. coli
Li Shen reports back on his AMI-sponsored summer studentship which investigated a novel antibiotic adjuvant at the Centre for Bacterial Resistance Biology, Imperial College London.
-
-
NewsScientist awarded $5 million to improve mental health and HIV care for adolescents in Uganda
The National Institutes of Health (NIH) has awarded Dr. Philip Kreniske $5,115,391 for a groundbreaking research project to improve mental health and antiretroviral treatment adherence among adolescents living with HIV in rural Uganda.
-
NewsGlobal Virus Network launches multi-country mpox diagnostic evaluation to close global preparedness gaps
The Global Virus Network has initiated one of the first coordinated, multi-country evaluations of rapid point-of-care mpox diagnostics, a critical step to prevent resurgence and ensure the world is better prepared for future epidemics.
-
NewsBeyond viruses: Expanding the fight against infectious diseases
The newly renamed Gladstone Infectious Disease Institute has broadened its mission to address global health threats ranging from antibiotic resistance to infections that cause chronic diseases.
-
NewsVirologist leading team to bolster Canada’s ability to respond to future pandemics, public health emergencies
With $3M in new federal funding over two years, University of Ottawa Faculty of Medicine molecular virologist Dr. Marc-André Langlois and a multidisciplinary team of collaborators will be a vital part of Canada’s ability to respond effectively to infectious disease threats & future pandemics.
-
NewsMore than 50 scientific societies issue letter to Congress expressing concerns regarding executive order on federal grantmaking
A coalition of more than 50 scientific societies has issued a letter to the United States Congress, expressing concerns over provisions in the 7 August 2025 Executive Order (EO) titled “Improving Oversight of Federal Grantmaking.”
-
NewsCholera vaccination campaign launched in Darfur to protect over 1.8 million people
A cholera vaccination campaign kicked off on 21 September 2025 in South Darfur, marking the start of a campaign that aims to reach 1.86 million people aged one year and older with oral vaccines in response to the ongoing outbreak.
-
NewsTropical diseases: Global health meeting showcases resilience of field under fire
At a moment of monumental challenges for global health, thousands of researchers, clinicians and public health professionals from over 100 countries will gather in Toronto for the 2025 Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH).
-
NewsGut punch: $2 million to decode bacteria’s role in fighting disease
A $2 million grant to UC Riverside will explore how gut bacteria shape human health. The NIH award will support Ansel Hsiao’s lab in its quest to answer questions about how gut microbes communicate with each other and with their human hosts to influence health.
-
NewsJie Xiao to receive 2026 Carolyn Cohen Innovation Award from The Biophysical Society
The Biophysical Society has announced that Jie Xiao, of the Johns Hopkins School of Medicine, USA, will receive the 2026 Carolyn Cohen Innovation Award.
-
NewsAMI joins forces with microbiology leaders to launch Global Climate Change Strategy
In a bold step toward climate action, leading microbiology societies and organizations have unveiled their first joint global strategy to harness the power of microbial science in addressing the climate crisis.
-
News‘We need to prepare for a growing number of West Nile virus infections,’ experts warn
Growing numbers of West Nile virus infection cases, fueled by climate change, are sparking fears among healthcare providers in Europe. A clinical insight aims to equip medical professionals with the knowledge needed to recognize and manage this emerging disease.
-
NewsMicrobes hold the key to combating climate disaster, say scientists
Global microbiology organisations including Applied Microbiology International (AMI) have called for urgent action to put microbes at the heart of climate change mitigation, in a high-level panel discussion chaired by AMI Chief Executive, Dr Lucy Harper.
-
NewsCattle vaccine immunity ‘boost’ tested by new research
Scientists at Aberystwyth University are leading research into how a widely used vaccine can boost overall immunity in livestock. The four-year study will investigate the concept of ‘trained immunity’ – a form of immune memory triggered by a vaccine.
-
NewsNIH grant aims for childhood vaccine against HIV
A multi-institutional team led by Weill Cornell Medicine investigators has been awarded a five-year, $20.8 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, for advanced preclinical development of a promising experimental HIV vaccine. Source: NIAID Transmission electron micrograph ...
-
NewsClass of 25: Letters in Applied Microbiology’s first Junior Editors pass with flying colours
Applied Microbiology International’s first ever cohort of Junior Editors completed their two-year training programme on August 31 - and have passed with flying colours.
-
NewsMicrobiotica announces completion of recruitment in its international phase 1b trial of microbiome co-therapy
Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces that patient recruitment is complete in its advanced melanoma (MELODY-1) trial.
-
NewsNew Center of Excellence to respond to the challenge of antibiotic-resistant bacteria
Boston Children’s Hospital and Tulane University have received $25 million in funding from NIAID/NIH to establish a Center of Excellence for Translational Research (CETR) called IMPACT (Immunization against Multidrug-resistant Pathogens: Activating T Cell Immunity).